Unity Biotechnology Stock Price on November 26, 2024
| UBX Stock | USD 1.24 0.03 2.48% |
Below is the normalized historical share price chart for Unity Biotechnology extending back to May 03, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Unity Biotechnology stands at 1.24, as last reported on the 30th of November, with the highest price reaching 1.25 and the lowest price hitting 1.21 during the day.
If you're considering investing in Unity Stock, it is important to understand the factors that can impact its price. Unity Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13% return per unit of risk over the last 3 months. Unity Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Unity Biotechnology's Variance of 6.03, coefficient of variation of (584.29), and Risk Adjusted Performance of (0.12) to confirm the risk estimate we provide.
At this time, Unity Biotechnology's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 100.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 27 M in 2024. . At this time, Unity Biotechnology's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 1.07 in 2024, whereas Price Earnings Ratio is likely to drop (0.75) in 2024. Unity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of May 2018 | 200 Day MA 1.4867 | 50 Day MA 1.3448 | Beta 0.827 |
Unity |
Sharpe Ratio = -0.1329
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UBX |
Estimated Market Risk
| 2.44 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Unity Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Unity Biotechnology by adding Unity Biotechnology to a well-diversified portfolio.
Price Book 1.4415 | Enterprise Value Ebitda (0.23) | Price Sales 6.5445 | Shares Float 14.7 M | Wall Street Target Price 7 |
Related Headline
Atea Pharmaceuticals Headline on 26th of November 2024
Atea Pharmaceuticals to Present and Provide a Business Updat... by finance.yahoo.com
BOSTON, Nov. 26, 2024 -- Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals, together with other members of the Atea management team, will participate in a fireside chat and present a business update at the 7th Annual Evercore He
Unity Biotechnology Valuation on November 26, 2024
It is possible to determine the worth of Unity Biotechnology on a given historical date. On November 26, 2024 Unity was worth 1.19 at the beginning of the trading date compared to the closed value of 1.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Unity Biotechnology stock. Still, in general, we apply an absolute valuation method to find Unity Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Unity Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Unity Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 1.17 | 1.20 | 1.16 | 1.19 | 51,209 | |
11/26/2024 | 1.19 | 1.22 | 1.17 | 1.21 | 65,647 |
| 1.25 | 1.25 | 1.19 | 1.21 | 30,597 |
| Backtest Unity Biotechnology | | | Unity Biotechnology History | | | Unity Biotechnology Valuation | Previous | Next |
Unity Biotechnology Trading Date Momentum on November 26, 2024
| On November 27 2024 Unity Biotechnology was traded for 1.21 at the closing time. Highest Unity Biotechnology's price during the trading hours was 1.25 and the lowest price during the day was 1.19 . The net volume was 30.6 K. The overall trading history on the 27th of November did not result in any price rise and fall. The trading price change to current price is 0.83% . |
Unity Biotechnology Fundamentals Correlations and Trends
By evaluating Unity Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Unity Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Unity financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Unity Biotechnology Stock history
Unity Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Unity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Unity Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Unity Biotechnology stock prices may prove useful in developing a viable investing in Unity Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.8 M | 15.5 M | |
| Net Loss | -53.9 M | -56.6 M |
Unity Biotechnology Quarterly Net Working Capital |
|
Unity Biotechnology Stock Technical Analysis
Unity Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Unity Biotechnology Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Unity Biotechnology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Unity Biotechnology November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Unity Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Unity Biotechnology shares will generate the highest return on investment. By undertsting and applying Unity Biotechnology stock market strength indicators, traders can identify Unity Biotechnology entry and exit signals to maximize returns
Unity Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Unity Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Unity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Unity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (1.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.